NCT00434785View on ClinicalTrials.gov

A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

February 28, 2007

Study Completion Date

September 30, 2007

Conditions

Healthy

Interventions

DRUG

AGG-523

Trial Locations (1)

1520003

Ikebukuro

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00434785 - A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males | Biotech Hunter | Biotech Hunter